Impact of the suspension and restart of the Dutch breast cancer screening program on breast cancer incidence and stage during the COVID-19 pandemic

A.H. Eijkelboom; L. de Munck; M.B.I. Lobbes; C.H. van Gils; J. Wesseling; P.J. Westenend; C.G. Paez; R.M. Pijnappel; H.M. Verkooijen; M.J.M. Broeders; S. Siesling; NABON COVID-19 Consortium and the COVID and Cancer-NL Consortium

doi:10.1016/j.ypmed.2021.106602

Impact of the suspension and restart of the Dutch breast cancer screening program on breast cancer incidence and stage during the COVID-19 pandemic

A.H. Eijkelboom, L. de Munck, M.B.I. Lobbes, C.H. van Gils, J. Wesseling, P.J. Westenend, C.G. Paez, R.M. Pijnappel, H.M. Verkooijen, M.J.M. Broeders, S. Siesling^*, NABON COVID-19 Consortium and the COVID and Cancer-NL Consortium

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

7 Citations (Web of Science)

Original language	English
Article number	106602
Number of pages	10
Journal	Preventive Medicine
Volume	151
DOIs	https://doi.org/10.1016/j.ypmed.2021.106602
Publication status	Published - 1 Oct 2021

Keywords

COVID-19
Breast cancer incidence
Breast cancer screening
cT-stage
Clinical tumor stage

Access to Document

10.1016/j.ypmed.2021.106602

Cite this

Eijkelboom, A. H., de Munck, L., Lobbes, M. B. I., van Gils, C. H., Wesseling, J., Westenend, P. J., Paez, C. G., Pijnappel, R. M., Verkooijen, H. M., Broeders, M. J. M., Siesling, S., & NABON COVID-19 Consortium and the COVID and Cancer-NL Consortium (2021). Impact of the suspension and restart of the Dutch breast cancer screening program on breast cancer incidence and stage during the COVID-19 pandemic. Preventive Medicine, 151, [106602]. https://doi.org/10.1016/j.ypmed.2021.106602

Eijkelboom, A.H. ; de Munck, L. ; Lobbes, M.B.I. ; van Gils, C.H. ; Wesseling, J. ; Westenend, P.J. ; Paez, C.G. ; Pijnappel, R.M. ; Verkooijen, H.M. ; Broeders, M.J.M. ; Siesling, S. ; NABON COVID-19 Consortium and the COVID and Cancer-NL Consortium. / Impact of the suspension and restart of the Dutch breast cancer screening program on breast cancer incidence and stage during the COVID-19 pandemic. In: Preventive Medicine. 2021 ; Vol. 151.

@article{2c1252473cf64131bd112faf9df20cdf,

title = "Impact of the suspension and restart of the Dutch breast cancer screening program on breast cancer incidence and stage during the COVID-19 pandemic",

keywords = "COVID-19, Breast cancer incidence, Breast cancer screening, cT-stage, Clinical tumor stage",

author = "A.H. Eijkelboom and {de Munck}, L. and M.B.I. Lobbes and {van Gils}, C.H. and J. Wesseling and P.J. Westenend and C.G. Paez and R.M. Pijnappel and H.M. Verkooijen and M.J.M. Broeders and S. Siesling and {NABON COVID-19 Consortium and the COVID and Cancer-NL Consortium}",

year = "2021",

month = oct,

day = "1",

doi = "10.1016/j.ypmed.2021.106602",

language = "English",

volume = "151",

journal = "Preventive Medicine",

issn = "0091-7435",

publisher = "Elsevier Science",

}

Eijkelboom, AH, de Munck, L, Lobbes, MBI, van Gils, CH, Wesseling, J, Westenend, PJ, Paez, CG, Pijnappel, RM, Verkooijen, HM, Broeders, MJM, Siesling, S & NABON COVID-19 Consortium and the COVID and Cancer-NL Consortium 2021, 'Impact of the suspension and restart of the Dutch breast cancer screening program on breast cancer incidence and stage during the COVID-19 pandemic', Preventive Medicine, vol. 151, 106602. https://doi.org/10.1016/j.ypmed.2021.106602

Impact of the suspension and restart of the Dutch breast cancer screening program on breast cancer incidence and stage during the COVID-19 pandemic. / Eijkelboom, A.H.; de Munck, L.; Lobbes, M.B.I.; van Gils, C.H.; Wesseling, J.; Westenend, P.J.; Paez, C.G.; Pijnappel, R.M.; Verkooijen, H.M.; Broeders, M.J.M.; Siesling, S.; NABON COVID-19 Consortium and the COVID and Cancer-NL Consortium.

In: Preventive Medicine, Vol. 151, 106602, 01.10.2021.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Impact of the suspension and restart of the Dutch breast cancer screening program on breast cancer incidence and stage during the COVID-19 pandemic

AU - Eijkelboom, A.H.

AU - de Munck, L.

AU - Lobbes, M.B.I.

AU - van Gils, C.H.

AU - Wesseling, J.

AU - Westenend, P.J.

AU - Paez, C.G.

AU - Pijnappel, R.M.

AU - Verkooijen, H.M.

AU - Broeders, M.J.M.

AU - Siesling, S.

AU - NABON COVID-19 Consortium and the COVID and Cancer-NL Consortium

PY - 2021/10/1

Y1 - 2021/10/1

KW - COVID-19

KW - Breast cancer incidence

KW - Breast cancer screening

KW - cT-stage

KW - Clinical tumor stage

U2 - 10.1016/j.ypmed.2021.106602

DO - 10.1016/j.ypmed.2021.106602

M3 - Article

C2 - 34217417

VL - 151

JO - Preventive Medicine

JF - Preventive Medicine

SN - 0091-7435

M1 - 106602

ER -